{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T19:57:52Z","timestamp":1762459072150},"reference-count":17,"publisher":"Public Library of Science (PLoS)","issue":"7","license":[{"start":{"date-parts":[[2013,7,16]],"date-time":"2013-07-16T00:00:00Z","timestamp":1373932800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0069845","type":"journal-article","created":{"date-parts":[[2013,7,16]],"date-time":"2013-07-16T21:12:42Z","timestamp":1374009162000},"page":"e69845","update-policy":"http:\/\/dx.doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":10,"title":["Is Ritonavir-Boosted Atazanavir a Risk for Cholelithiasis Compared to Other Protease Inhibitors?"],"prefix":"10.1371","volume":"8","author":[{"given":"Yohei","family":"Hamada","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takeshi","family":"Nishijima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hirokazu","family":"Komatsu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katsuji","family":"Teruya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroyuki","family":"Gatanaga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshimi","family":"Kikuchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shinichi","family":"Oka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2013,7,16]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1097\/00126334-200408150-00003","article-title":"Comparison of once-daily atazanavir with efavirenz, each in combination with fixed-dose zidovudine and lamivudine, as initial therapy for patients infected with HIV","volume":"36","author":"K Squires","year":"2004","journal-title":"J Acquir Immune Defic Syndr"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1097\/QAI.0b013e3181c990bf","article-title":"Once-daily atazanavir\/ritonavir compared with twice-daily lopinavir\/ritonavir, each in combination with tenofovir and emtricitabine, for management of antiretroviral-naive HIV-1-infected patients: 96-week efficacy and safety results of the CASTLE study","volume":"53","author":"JM Molina","year":"2010","journal-title":"J Acquir Immune Defic Syndr"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1093\/cid\/cis621","article-title":"High incidence of renal stones among HIV-infected patients on ritonavir-boosted atazanavir than in those receiving other protease inhibitor-containing antiretroviral therapy","volume":"55","author":"Y Hamada","year":"2012","journal-title":"Clin Infect Dis"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1093\/cid\/cis620","article-title":"Complicated atazanavir-associated cholelithiasis: a report of 14 cases","volume":"55","author":"S Rakotondravelo","year":"2012","journal-title":"Clin Infect Dis"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1093\/jac\/dkr435","article-title":"Unexpected atazanavir-associated biliary lithiasis in an HIV-infected patient","volume":"67","author":"E Courbon","year":"2012","journal-title":"J Antimicrob Chemother"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1345\/aph.1M489","article-title":"Atazanavir-associated choledocholithiasis leading to acute hepatitis in an HIV-infected adult","volume":"44","author":"AC Jacques","year":"2010","journal-title":"Ann Pharmacother"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"e57","DOI":"10.1086\/341982","article-title":"Indinavir-induced cholelithiasis in a patient infected with human immunodeficiency virus","volume":"35","author":"R Verdon","year":"2002","journal-title":"Clin Infect Dis"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1086\/374875","article-title":"Cholelithiasis possibly induced by protease inhibitors in 3 patients","volume":"36","author":"JT Siveke","year":"2003","journal-title":"Clin Infect Dis"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/0021-9681(66)90132-9","article-title":"The epidemiology of gallbladder disease: observations in the Framingham Study","volume":"19","author":"GD Friedman","year":"1966","journal-title":"J Chronic Dis"},{"key":"ref10","first-page":"460","article-title":"The mechanism of increased gallstone formation in obese human subjects","volume":"79","author":"TM Mabee","year":"1976","journal-title":"Surgery"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"247","DOI":"10.7326\/0003-4819-145-4-200608150-00004","article-title":"Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate","volume":"145","author":"AS Levey","year":"2006","journal-title":"Ann Intern Med"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1097\/QAD.0b013e32834a1cd6","article-title":"Ritonavir-boosted atazanavir exposure is associated with an increased rate of renal stones compared with efavirenz, ritonavir-boosted lopinavir and ritonavir-boosted darunavir","volume":"25","author":"N Rockwood","year":"2011","journal-title":"AIDS"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"e105","DOI":"10.1086\/521930","article-title":"Urolithiasis in HIV-positive patients treated with atazanavir","volume":"45","author":"C Couzigou","year":"2007","journal-title":"Clin Infect Dis"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1097\/QAD.0b013e32813aee35","article-title":"Atazanavir-associated nephrolithiasis: cases from the US Food and Drug Administration's Adverse Event Reporting System","volume":"21","author":"KM Chan-Tack","year":"2007","journal-title":"AIDS"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"2158","DOI":"10.1056\/NEJMc061892","article-title":"Atazanavir urolithiasis","volume":"355","author":"HR Chang","year":"2006","journal-title":"N Engl J Med"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1007\/s00240-008-0147-3","article-title":"Acute renal failure due to bilateral ureteral stone impaction in an HIV-positive patient","volume":"36","author":"Y Moriyama","year":"2008","journal-title":"Urol Res"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.gtc.2010.02.003","article-title":"Epidemiology of gallstones","volume":"39","author":"LM Stinton","year":"2010","journal-title":"Gastroenterol Clin North Am"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0069845","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,10,26]],"date-time":"2018-10-26T00:09:27Z","timestamp":1540512567000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0069845"}},"subtitle":[],"editor":[{"given":"Wenzhe","family":"Ho","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2013,7,16]]},"references-count":17,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2013,7,16]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0069845","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,7,16]]}}}